Inflammatory signals, including IL-1, IL-6, IL-9, IL-17, interferon-gamma (IFN-), TNF-, and chemokine ligand 2 (CCL2), contribute to diminished TJs expression or misallocation [114,115,116,117,118,119]
This provided encouraging evidence for its potential role as a radiosensitizer in the treatment of clinical osteosarcoma
Following recommended storage practices helps maintain product quality during scientific research
NICE published TA875 in 2023, recommending Wegovy for the management of overweight and obesity in eligible adults
Gastrointestinal adverse events were the most frequently reported side effects, occurring in 79.6% of participants on CagriSema in REDEFINE 1, compared with 39.9% on placebo
The FDA might approve it in June 2025, which would be exciting news for HAE patients